1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "103429-32-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-P1335

    Opioid Receptor Neurological Disease
    CTAP is a potent, highly selective, and brain penetrant μ opioid receptor antagonist (IC50=3.5 nM) and displays over 1200-fold selectivity over δ opioid (IC50=4500 nM) and somatostatin receptors. CTAP can be used for the study of L-DOPA-induced dyskinesia (LID).